The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Evaluation of therapeutic targets in animal models of arthritis: How does it relate to rheumatoid arthritis?
Abstract
Introduction Rheumatoid arthritis (RA) is a chronic, systemic, immune-mediated inflammatory disease associated with decreased life expectancy and quality of life. RA is characterized by chronic inflammation and synovial hyperplasia leading to destruction of cartilage and bone. A better understanding of the pathophysiology of RA has led to significant improvements in its treatment. However, many questions remain with respect to the pathogenesis of RA, and disease remission is achieved in only a minority of patients. Therefore, there is still a need to develop novel antirheumatic therapies. Animal models of RA complement descriptive studies of well-defined patient samples and in vitro studies and represent important tools for the development and evaluation of new treatment options. This review article addresses the immunologic characteristics of and similarities and differences between a variety of animal models of human RA. Commonly used animal models such as collagen-induced arthritis (CIA), adjuvant-induced arthritis (AIA), and a model of spontaneous arthritis using tumor necrosis factor (TNF)–transgenic mice are described. We also discuss the less frequently used models of streptococcal cell wall (SCW)–induced arthritis, proteoglycan-induced arthritis (PGIA), and K/BxN-transgenic mice, including the serum transfer–induced (STIA) model, to indicate the variety of animal models with specific characteristics that are available and that could be used to study specific components and stages of the inflammation process. Furthermore, we describe the effects of some targeted interventions, comparing animal studies with clinical trials. Finally, the importance of choosing a suitable animal model of arthritis for screening the preclinical efficacy of newly developed therapeutics is addressed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
American college of rheumatology preliminary definition of improvement in rheumatoid arthritis
Felson, D. T., Anderson, J. J., Boers, M., Bombardier, C., Furst, D., Goldsmith, C., Katz, L. M., Lightfoot, R., Paulus, H., Strand, V., et al. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380602 · Cited by 2,829
Cytokines in the pathogenesis of rheumatoid arthritis
McInnes, I. B., & Schett, G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2094 · Cited by 2,529
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.
Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D., & Kollias, G. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04978.x · Cited by 1,660
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Tracey, D., Klareskog, L., Sasso, E. H., Salfeld, J. G., & Tak, P. P. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.10.001 · Cited by 1,628
Self-citationEmery, P., Keystone, E., Tony, H. P., Cantagrel, A., van Vollenhoven, R., Sanchez, A., Alecock, E., Lee, J., & Kremer, J. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.092932 · Cited by 1,104
Evidence that cytokines play a role in rheumatoid arthritis
Brennan, F. M., & McInnes, I. B. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36389 · Cited by 1,103
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
Elliott, M. J., Maini, R. N., Feldmann, M., Long‐Fox, A., Charles, P., Katsikis, P., Brennan, F. M., Walker, J., Bijl, H., Ghrayeb, J., et al. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780361206 · Cited by 1,038
Immunisation against heterologous type II collagen induces arthritis in mice
Courtenay, J. S., Dallman, M. J., Dayan, A. D., Martin, A., & Mosedale, B. (1980) · Nature · doi:10.1038/283666a0 · Cited by 1,025
Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
Williams, R. O., Feldmann, M., & Maini, R. N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9784 · Cited by 989
Development of Arthritis, Periarthritis and Periostitis in Rats Given Adjuvants.
Pearson, C. M. (1956) · Experimental Biology and Medicine · doi:10.3181/00379727-91-22179 · Cited by 842
Cited by
Tests and models of nociception and pain in rodents
Barrot, M. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2011.12.041 · Cited by 483
Keystone, E. C., Wang, M. M., Layton, M., Hollis, S., & McInnes, I. B. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-143578 · Cited by 315
Co-stimulatory and Co-inhibitory Pathways in Autoimmunity
Zhang, Q., & Vignali, D. A. A. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.017 · Cited by 296
Experimental animal models for rheumatoid arthritis
Choudhary, N., Bhatt, L. K., & Prabhavalkar, K. S. (2018) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2018.1434793 · Cited by 295
T cell migration in rheumatoid arthritis
Mellado, M. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00384 · Cited by 291
Metadata
- Authors
- Bevaart, L., Vervoordeldonk, M. J., & Tak, P. P.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2010-08
- Volume
- 62
- Issue
- 8
- Pages
- 2192-2205
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2140016144
- Cited by
- 253
- References
- 98
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evaluation of therapeutic targets in animal models of arthritis: How does it relate to rheumatoid arthritis? https://app.cochat.ai/papers/10.1002/art.27503
- The paper
- Bevaart, L., Vervoordeldonk, M. J., & Tak, P. P. (2010). Evaluation of therapeutic targets in animal models of arthritis: How does it relate to rheumatoid arthritis? Arthritis & Rheumatism. https://doi.org/10.1002/art.27503
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.